Advanced Search

 

Study ID Status Title Patient Level Data
110478 Completed Immunogenicity and reactogenicity study of a new formulation of GSK Biologicals' DTPa-HBV-IPV/Hib vaccine administered as a booster dose to 18-23 months old children Study Listed on ClinicalStudyDataRequest.com
110502 Completed A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2007 – 2008 Season) in Adults Ranging in Age from 18 to 60 Years and 61 Years and Over Study Listed on ClinicalStudyDataRequest.com
110521 Completed Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A co-administered with Zilbrix™ Hib and Polio Sabin™ Study Listed on ClinicalStudyDataRequest.com
110584 Completed Immunogenicity and safety study of a single injection of GSK Biologicals' Trivalent Split virion Influenza vaccine Fluviral® (2008 - 2009 Season) in adults aged 18 to 60 years and over 60 years. Study Listed on ClinicalStudyDataRequest.com
110586 Completed Immunogenicity and safety study of GSK Biologicals’ Trivalent Split Virion Influenza Vaccine Fluviral® (2009 - 2010 Season) in adults aged 18 to 60 years and over 60 years. Study Listed on ClinicalStudyDataRequest.com
110620 Completed Non-Inferiority of GlaxoSmithKline Biologicals' Influenza Vaccine (GSK576389A) 1 Container Over 2 Container Presentation in Adults Aged 65 Years and Over Study Listed on ClinicalStudyDataRequest.com
110624 Completed A trial to evaluate the safety and immunogenicity of monovalent H5N1 vaccine in adults >=18 yrs of age Study Listed on ClinicalStudyDataRequest.com
110628 Completed Immunogenicity and safety study of GSK Biologicals’ (GSK1536489A) Trivalent Split Virion Influenza Vaccine Fluviral® (2010 - 2011 Season) in adults aged 18 to 60 years and over 60 years. Study Listed on ClinicalStudyDataRequest.com
110635 Terminated A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who have had an inadequate response to methotrexate therapy
110651 Completed A randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of the H3 receptor antagonist, GSK239512 in subjects with mild to moderate Alzheimer’s disease. Study Listed on ClinicalStudyDataRequest.com
110659 Completed Evaluation of the safety and immunogenicity of GSK Biologicals' HPV vaccine 580299 when administered in healthy females aged 9 - 25 years using an alternative schedule and an alternative dosing as compared to the standard schedule and dosing Study Listed on ClinicalStudyDataRequest.com
110674 Completed Safety and Immunogenicity of a Second Vaccination With GSK Biologicals' Influenza Vaccine GSK1247446A in Subjects 18-60 Years Previously Vaccinated in Study 108656 Study Listed on ClinicalStudyDataRequest.com
110699 Completed An open multicentre, multicountry study to evaluate long-term antibody persistence and immune memory between Years 11 and 15 after the primary study HAB-084 in which healthy adolescents were vaccinated with Twinrix™ Adult following a two-dose schedule or Twinrix™ Junior following a three-dose schedule. Study Listed on ClinicalStudyDataRequest.com
110762 Completed A randomised, placebo-controlled, incomplete block, three-way cross-over study to evaluate the effect of treatment with repeat inhaled doses of GW870086X on the allergen-induced early and late asthmatic response in subjects with mild asthma Study Listed on ClinicalStudyDataRequest.com
110771 Completed An open label positron emission tomography (PET) study to investigate brain penetration by [11C] GSK1034702 in healthy subjects Study Listed on ClinicalStudyDataRequest.com
110792 Completed A placebo-controlled, single-blind, randomised study to investigate the safety, tolerability, pharmacokinetics and drug interaction of GSK1034702 after repeat doses in healthy subjects Study Listed on ClinicalStudyDataRequest.com
110794 Completed Immunogenicity, safety and reactogenicity of GSK Biologicals' influenza vaccine GSK1247446A with various formulations in subjects aged 18-64 years Study Listed on ClinicalStudyDataRequest.com
110804 Completed Evaluation of GSK Biologicals’ dTpa booster vaccine in adults, given 10 years after previous dTpa boosting. Study Listed on ClinicalStudyDataRequest.com
110806 Completed Evaluation of GSK Biologicals’ dTpa booster vaccine in young adults 10 years after previous dTpa boosting. Study Listed on ClinicalStudyDataRequest.com
110808 Completed Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A or Prevenar™ co-administered with Hiberix™ Study Listed on ClinicalStudyDataRequest.com
110847 Completed Observer blind immunogenicity and safety study of GlaxoSmithKline Biologicals' influenza vaccine GSK576389A with various formulations in adults aged 65 years and above Study Listed on ClinicalStudyDataRequest.com
110847 Completed Observer blind immunogenicity and safety study of GlaxoSmithKline Biologicals' influenza vaccine GSK576389A with various formulations in adults aged 65 years and above Study Listed on ClinicalStudyDataRequest.com
110852 Completed MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration
110870 Completed Immunogenicity and safety study of a booster dose of GSK Biologicals’ meningococcal vaccine 134612 given at 12-15 months of age or at 15-18 months of age (co-administered with Infanrix®) in primed healthy toddlers. Study Listed on ClinicalStudyDataRequest.com
110876 Completed Immunogenicity & safety study of GSK Biologicals’ combined measles-mumps-rubella-varicella vaccine 208136 Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.